Quality of Life Impact of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma

Publication date: Available online 18 September 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Pierluigi Porcu, Stacie Hudgens, Steven Horwitz, Pietro Quaglino, Richard Cowan, Larisa Geskin, Marie Beylot-Barry, Lysbeth Floden, Martine Bagot, Athanasios Tsianakas, Alison Moskowitz, Auris Huen, Brigitte Dreno, Stéphane Dalle, Dolores Caballero, Mollie Leoni, Stephen Dale, Fiona Herr, Madeleine Duvic
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research